It was the birthplace of the liberal tradition, but also the incubator for Nazism – what can this historic city tell us about democracy? ‘Weimar is Germany in a nutshell,” 1990s president Roman Herzog once quipped: “a town in which not only culture and thought were at home but also philistinism and barbarism.” The small city (population 65,000) sits at the heart of the nation and acts as a shrine ...
It was the birthplace of the liberal tradition, but also the incubator for Nazism – what can this historic city tell us about democracy? ‘Weimar is Germany in a nutshell,” 1990s president Roman Herzog once quipped: “a town in which not only culture and thought were at home but also philistinism and barbarism.” The small city (population 65,000) sits at the heart of the nation and acts as a shrine to its sons Goethe, Schiller and Nietzsche. In 1919 the country’s first democratic constitution was promulgated in its national theatre. It was chosen as the site of Germany’s rebirth precisely because its aura of refined culture contrasted so sharply with the “Prussian militarism” of Berlin. From 1919-1925 it hosted the Bauhaus School, led by Walter Gropius, placing it at the forefront of art and design. Yet, starting in the mid-1920s, Weimar, which is also the state capital of Thuringia, became pivotal in the rise of the Nazi party and its first, regional, experiments in government. After 1933 it competed with Bayreuth for recognition as the “spiritual home of Nazism”. Continue reading...
The Guardian’s David Levene braved two-headed worms, Pussy Riot protests and a tank of urine to bring you this photographic extravaganza from the celebrated arts festival Continue reading...
The Guardian’s David Levene braved two-headed worms, Pussy Riot protests and a tank of urine to bring you this photographic extravaganza from the celebrated arts festival Continue reading...
China’s first internationally certified female professional tree climber has turned a fear of heights into a career spent high in the canopy, pruning urban trees. Yu Yanling, a former track athlete from Xiamen in southeastern China’s Fujian province, was once afraid of heights. Now in her 30s, she has climbed trees as tall as 60 metres. She discovered the sport by chance at university, after seein...
China’s first internationally certified female professional tree climber has turned a fear of heights into a career spent high in the canopy, pruning urban trees. Yu Yanling, a former track athlete from Xiamen in southeastern China’s Fujian province, was once afraid of heights. Now in her 30s, she has climbed trees as tall as 60 metres. She discovered the sport by chance at university, after seeing students suspended from branches by ropes and witnessing the joy it brought them, according to the...
Malaysian Home Minister Saifuddin Nasution Ismail has dismissed allegations that citizenship was arbitrarily granted to Chinese nationals, calling the claims “malicious slander” and fake news intended to incite public sentiment. He said the accusations were irresponsible and should not be weaponised for political purposes, especially at a time when the government is focused on helping the people n...
Malaysian Home Minister Saifuddin Nasution Ismail has dismissed allegations that citizenship was arbitrarily granted to Chinese nationals, calling the claims “malicious slander” and fake news intended to incite public sentiment. He said the accusations were irresponsible and should not be weaponised for political purposes, especially at a time when the government is focused on helping the people navigate the global supply crisis. He said he had repeatedly clarified the matter in parliament and...
The UK's New Multinational Naval Initiative Aims To Contain Russia In The Arctic & Baltic Authored by Andrew Korybko, General Sir Gwyn Jenkins, head of the British Royal Navy, announced that his counterparts from the 10-nation Joint Expeditionary Taskforce comprised of the UK, Norway, Sweden, Denmark, Finland, Iceland, Estonia, Latvia, Lithuania and the Netherlands agreed to create “a family of al...
The UK's New Multinational Naval Initiative Aims To Contain Russia In The Arctic & Baltic Authored by Andrew Korybko, General Sir Gwyn Jenkins, head of the British Royal Navy, announced that his counterparts from the 10-nation Joint Expeditionary Taskforce comprised of the UK, Norway, Sweden, Denmark, Finland, Iceland, Estonia, Latvia, Lithuania and the Netherlands agreed to create “a family of allied fleets” . Officially known as the “Northern Navies Initiative” (NNI), it’s explicitly aimed at containing Russia in the Arctic and Baltic. This represents the evolution of the UK’s Arctic-Baltic policy that was elaborated on last summer here . Estonia, at the far end of the Baltic Sea in proximity to St. Petersburg, was identified as the eastern lynchpin of this strategy with Greenland now becoming its western one. The inclusion of (for now still Denmark’s) Greenland, Iceland, and of course the UK hypothetically enables this “family of allied fleets” to monitor the so-called GIUK gap, which is Russia’s Arctic gateway to the Atlantic. Denmark also controls the Baltic Straits so the NNI can indeed potentially blockade Russia to an extent. As was explained here last month, however, any blockade would be an act of war that could prompt Russia to consider resorting to kinetic action in self-defense if its warnings go unheeded. Nevertheless, just like the US has (reportedly imperfectly) blockaded Iran , so too is it preparing to blockade China at the Strait of Malacca one day through its new military partnership with Indonesia and might thus also approve of the UK-led NNI preparing to blockade Russia in the GIUK gap and Baltic Straits one day too. It’s impossible to predict what exactly might happen, let alone the precise sequence of events that could unfold, but three more points of insight can be shared about the NNI for observers’ benefit. The first is that Poland is still conspicuously absent from the Joint Expeditionary Taskforce, the basis upon which the NNI is being a...
The US-China summit is “extremely important” to arrest the downward spiral of relations between the two countries, according to Li Cheng, a leading Chinese academic. But a summit would not be enough to change the overall structure of ties, which had been fraught for years, Li said on Thursday as US President Donald Trump began the first full day of his state visit to Beijing – the first by an Amer...
The US-China summit is “extremely important” to arrest the downward spiral of relations between the two countries, according to Li Cheng, a leading Chinese academic. But a summit would not be enough to change the overall structure of ties, which had been fraught for years, Li said on Thursday as US President Donald Trump began the first full day of his state visit to Beijing – the first by an American leader since 2017. The two presidents began the day with two hours of talks at the Great Hall...
Editor's note: Seeking Alpha is proud to welcome Beta Sigma Quant as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » JonnyJim/iStock via Getty Images Thesis I believe the current valuation of EyePoint ( EYPT ) ref...
Editor's note: Seeking Alpha is proud to welcome Beta Sigma Quant as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » JonnyJim/iStock via Getty Images Thesis I believe the current valuation of EyePoint ( EYPT ) reflects either a higher perception of clinical and regulatory risk or a more cautious view on DURAVYU's commercial potential. In my central case, the stock offers roughly 2x upside. In my view, EYPT is a clear BUY driven by a meaningful durability advantage that should translate into reduced treatment burden. My valuation reflects a probability-weighted outcome. Positive results would likely drive a significant re-rating, whereas failure would lead to a very substantial decline in EYPT value. EyePoint EyePoint is a clinical-stage biotech company developing therapeutics for retinal diseases. The company's website indicates that its " lead product candidate, DURAVYU™ (vorolanib intravitreal insert), is presently in Phase 3 clinical trials for neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). " Despite annual revenues of approximately $30 million in 2025, the company's market capitalization stood at approximately $1.14 billion as of May 12, 2026; the current valuation is largely driven by expectations around DURAVYU. According to management , top-line Phase 3 data in wet AMD are expected beginning mid-2026. The main value driver is the potential entry of DURAVYU into the wet AMD market, an approximately $10 billion market. Some reports indicate an expected 6% - 9% annual growth rate fuelled by increased prices in treatments and an aging population. The DME indication - an approximately $4 billion market - may provide a significant incremental value. The Wet AMD Market Wet AMD primarily affects an elderly population. Most patients are in the...
Manipal Health Enterprises Pvt. , which runs the Manipal Hospitals chain, is set to begin formal marketing as early as next week for its planned initial public offering to raise more than $1 billion, according to people familiar with the matter. The Temasek Holdings Pte. -backed company is targeting a valuation of about $12 billion during two weeks of meetings with domestic and international inves...
Manipal Health Enterprises Pvt. , which runs the Manipal Hospitals chain, is set to begin formal marketing as early as next week for its planned initial public offering to raise more than $1 billion, according to people familiar with the matter. The Temasek Holdings Pte. -backed company is targeting a valuation of about $12 billion during two weeks of meetings with domestic and international investors, the people said, asking not to be identified because the information is private. Deliberations are ongoing and details of the offering including its size and timing could still change, the people said. A representative for Manipal Hospitals didn’t immediately respond to requests for comment. Indian equity markets are gradually recovering from recent declines linked to geopolitical tensions in the Middle East, alongside government efforts to stabilize the fiscal outlook. Manipal Hospitals filed its draft prospectus with India’s market regulator in March. The proposed share sale includes a secondary offering of as many as 43.23 million shares, or about a 3.66% stake, by existing investors, as well as a fresh issue of shares worth about 80 billion rupees ($960 million), according to the filing. Selling shareholders in the secondary portion include TPG, Temasek, Ammar Sdn. Bhd., Novo Holdings Invest Asia, Phoenix Bear Investments LLC, Seventy Second Investment Company LLC and Manipal Education and Medical Group India Pvt. Ltd. For the latest news on equity capital markets activity in the Asia-Pacific region, follow the channel or visit NI BFWECMAS . To subscribe to ECM Watch , Bloomberg’s daily roundup of news from around the region, click here . The company is working with advisers including Kotak Mahindra Capital Co., Axis Bank Ltd., and the local units of Goldman Sachs Group Inc., JPMorgan Chase & Co., Jefferies Financial Group Inc., UBS Securities and DBS Bank Ltd. on the potential listing, according to the prospectus.